Document is current
Any future updates will be listed below
-
Authors
Zhang, Xiaolan
Xie, Jingjing
Wang, Heng
Li, Jun
-
Funding
Funding for this research was provided by:
Research Project of Jiangsu Provincial Health Commission (No. Z2018004)
Research Project of Jiangsu Provincial Administration of Traditional Chinese Medicine (No. YB201812，MS2023016)
The Fifth Batch of National Excellent Clinical Talents Training Program for Traditional Chinese Medicine (Letter No. 2022-1 from the Personnel Education Department of the State Administration of Traditional Chinese Medicine)
Research Project of Jiangsu Province Hospital of Chinese Medicine (No. Y22063)
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 10 June 2025
First Online: 19 August 2025
Declarations
:
: The authors declare no competing interests.
: In accordance with the National Health Commission of China “Measures for Ethical Review of Biomedical Research Involving Humans” (2016), CFDA “Good Practice for Quality Management of Drug Clinical Trials” (2003), WMA Declaration of Helsinki and CIOMS “Guidelines for International Ethical Review of Biomedical Research Involving Humans” Ethical principles, the studies involving human participants were reviewed and approved by the Ethics Committee of Affiliated Hospital of Nanjing University of Chinese Medicine (Ethical approval No. 2018NL-060-02). The patients/participants provided their written informed consent to participate in this study.
